Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORCE: FOcal Radiation for Oligometastatic Castration-Resistant Prostate Cancer
NCT03556904Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Dec 2018
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in prostate cancer (PCa) (2 arms), sponsored by University of Michigan Rogel Cancer Center. Primary endpoint: Duration of Response at 12 months. Started Dec 2018; status: completed.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03556904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03556904.